Showing results (161-170 of 183) with videos related to
Sort By:
Pageof 19
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspectsDrummond E-Wen McCulloch, Matthias E Liechti, Kim Pc Kuypers, et al.Journal of Psychopharmacology (Oxford, England)|April 24, 2019
Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivityMatthew B Wall, Rebecca Pope, Tom P Freeman, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 13, 2016
Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and geneticsBorwin Bandelow, David Baldwin, Marianna Abelli, et al.The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.Comprehensive Psychiatry|July 6, 2025
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyLuca Pellegrini, Naomi A Fineberg, Sorcha O'Connor, et al.Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.Addiction (Abingdon, England)|September 30, 2021
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis useValentina Lorenzetti, Chandni Hindocha, Kat Petrilli, et al.Nature Medicine|February 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trialDavid Erritzoe, Tommaso Barba, Tiffanie Benway, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 20, 2025
A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of ConsciousnessNaji L N Alnagger, Paolo Cardone, Charlotte Martial, et al.Journal of Psychopharmacology (Oxford, England)|June 16, 2020
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experimentAnna Borissova, Bart Ferguson, Matthew B Wall, et al.Pageof 19